ETCAMAH
Live / Registered — Registered (as of 11 Aug 2026)
What this means for you
Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 99208291
- Registration number
- 8387762
- Mark type
- Word mark
- Filed
- 29 May 2025
- Published for opposition
- 29 Jul 2025
- Registered
- 11 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)
- Attorney of record
- Leonid Rakitin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal, and immune systems; Vaccines; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Pharmaceutical preparations for use in oncology
Owner
- AstraZeneca AB, Sodertalje, SE
- AstraZeneca AB, Sodertalje, SE
- AstraZeneca AB, Sodertalje, SE
Prosecution history
- 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jul 2026 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 13 Jan 2026 — NOTICE OF ALLOWANCE CANCELLED
- 13 Jan 2026 — TEAS DELETE 1(B) BASIS RECEIVED
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2025 — ASSIGNED TO EXAMINER
- 29 May 2025 — APPLICATION FILING RECEIPT MAILED